FT News Briefing

2026-10-23 · Hosted by — · Financial Times

Executive Summary

Global stocks ended the week on a sour note Thursday, with Brent crude jumping above $113 a barrel and the Nasdaq 100 closing down nearly 3%, as Meta spooked investors by disclosing it needs to raise "hundreds of billions of dollars" over the next several years to fund its AI bet. The 10-year US Treasury yield dropped below 5% for the first time in over a month, as investors sought safety. Separately, Brazil's presidential runoff looms this Sunday, with Flavio Bolsonaro — son of jailed former president Jair Bolsonaro — having outperformed incumbent Lula in the first round.

Key Stories & Changes

1. Global Stock Sell-Off on Meta's AI Spending Disclosure

  • Brent crude jumped to above $113 a barrel; risky segments of the European bond market sold off alongside European and US stocks.

  • Nasdaq 100 closed down nearly 3% on Thursday.

  • The catalyst: Meta disclosed it needs to raise "hundreds of billions of dollars" over the next several years to fund its AI investment.

  • US 10-year Treasury yield dropped below 5% for the first time in over a month, reflecting a flight to safety.

2. US Prepared for Protracted Iran Conflict

  • US ambassador to the UN Mike Waltz told the FT the US is prepared for a long conflict, declining to rule out the current stalemate persisting a year from now.

  • The Iran war, now roughly eight months old, was originally expected by Trump to last four to five weeks.

  • Waltz said the "maximum pressure campaign is only tightening" and that the US Navy can maintain its blockade "for the foreseeable future."

  • The FT's Abigail Haus Loner noted administration officials beyond Trump increasingly acknowledge they cannot set an end date, while Iran shows no sign of willingness to make concessions.

  • Timing is notable: comments come two weeks before the US midterms, with Americans already facing high prices from the war's energy market fallout.

3. Brazil's Presidential Runoff

  • Brazil heads to a second-round vote starting Sunday between incumbent Lula and Flavio Bolsonaro, son of jailed former president Jair Bolsonaro.

  • Bolsonaro outperformed first-round polling, securing 47% of the vote despite most polls projecting a Lula win.

  • Lula's campaign has overhauled its digital/social media strategy and is highlighting Bolsonaro's proposed 2% of GDP spending cuts as a threat to social programs.

  • Analysts frame Bolsonaro's strong showing as reflecting voter discontent over cost of living and rising drug-gang-related security concerns, and a general desire for change after Lula's third term.

4. Western Drugmakers Shift Clinical Trials to China

  • AstraZeneca, Sonobiotechnology, and Tempest Therapeutics are among companies increasingly running early-stage ("IIT" — investigator-initiated trials) studies in China.

  • Drivers: a favorable regulatory environment for experimental therapies and a very large population, many without access to top-class medical care, willing to participate.

  • Benefit to pharma companies: faster patient recruitment (a process that might take six months to a year in a London hospital can be completed much faster in China), directly affecting biotech company timelines and valuations.

  • Risk flagged: some hospitals have had "sketchy" approaches to informed consent, though China has begun tightening rules to address this.

  • Framed as part of China's broader industrial strategy shift from basic manufacturing outsourcing toward becoming a source of genuine innovation.

5. UK Considers Raising Bank Profits Surcharge Tax

  • UK Chancellor is reportedly considering raising the bank profits surcharge tax from 3% to as high as 8% on profits above £100 million earned in the UK.

  • Would reverse a tax break introduced by former PM Rishi Sunak in 2021.

  • Banks are lobbying against the change, arguing it reduces UK competitiveness versus larger US counterparts.

  • The FT's banking editor said banks are unlikely to relocate over the tax change, though some international banks could shift bankers or investment elsewhere.

1. AI Spending Disclosures Are Now a Direct Macro Market-Mover

Meta's disclosure of needing "hundreds of billions" in AI funding triggered a broad risk-off move across equities, bonds, and oil — illustrating how a single company's capex guidance is now capable of moving global markets well beyond its own sector.

2. Political Calendars Are Shaping Both War and Fiscal Policy Timing

Both the Iran conflict's trajectory and the UK's bank tax decision appear tied to political timing — the US midterms for Iran messaging, and an imminent UK budget for the bank surcharge — reflecting how electoral and fiscal calendars increasingly drive policy announcements.

3. China's Rising Role in Global Pharma Innovation

The shift of Western drug trials to China, described as moving "up the value chain" from manufacturing outsourcing to genuine R&D innovation, mirrors a broader pattern of China becoming central to global biotech and tech supply chains alike. ---

Sentiment Analysis

Overall Market Sentiment: Risk-Off

The sell-off in stocks, rotation into bonds, and rising oil prices reflect a broadly defensive market posture driven by AI spending concerns and geopolitical escalation.

Risk Factors Highlighted

AI capex funding scale: Meta's need to raise "hundreds of billions of dollars" is directly linked to a global market sell-off.

Protracted Iran conflict: US officials declining to set an end date raises risk of sustained energy price pressure and economic fallout.

Midterm election timing pressure: Iran war escalation decisions appear influenced by political calculations around the upcoming midterms.

Brazil election uncertainty: A closely contested runoff introduces policy uncertainty for Latin America's largest economy.

Clinical trial informed-consent risk: Some Chinese hospitals' "sketchy" consent practices raise ethical concerns even as trial speed improves.

UK bank competitiveness risk: A sharp bank surcharge tax hike could disadvantage UK-based banks relative to US counterparts, per industry argument.

This episode was covered in today's [The Market Signal — 2026-10-23](https://marketsignal.beehiiv.com/p/the-market-signal-2026-10-23), a cross-source synthesis of multiple podcast reports.

Keep Reading